Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 21;48(4):881-892.
doi: 10.1093/schbul/sbac047.

Graph Convolutional Networks Reveal Network-Level Functional Dysconnectivity in Schizophrenia

Affiliations

Graph Convolutional Networks Reveal Network-Level Functional Dysconnectivity in Schizophrenia

Du Lei et al. Schizophr Bull. .

Abstract

Background and hypothesis: Schizophrenia is increasingly understood as a disorder of brain dysconnectivity. Recently, graph-based approaches such as graph convolutional network (GCN) have been leveraged to explore complex pairwise similarities in imaging features among brain regions, which can reveal abstract and complex relationships within brain networks.

Study design: We used GCN to investigate topological abnormalities of functional brain networks in schizophrenia. Resting-state functional magnetic resonance imaging data were acquired from 505 individuals with schizophrenia and 907 controls across 6 sites. Whole-brain functional connectivity matrix was extracted for each individual. We examined the performance of GCN relative to support vector machine (SVM), extracted the most salient regions contributing to both classification models, investigated the topological profiles of identified salient regions, and explored correlation between nodal topological properties of each salient region and severity of symptom.

Study results: GCN enabled nominally higher classification accuracy (85.8%) compared with SVM (80.9%). Based on the saliency map, the most discriminative brain regions were located in a distributed network including striatal areas (ie, putamen, pallidum, and caudate) and the amygdala. Significant differences in the nodal efficiency of bilateral putamen and pallidum between patients and controls and its correlations with negative symptoms were detected in post hoc analysis.

Conclusions: The present study demonstrates that GCN allows classification of schizophrenia at the individual level with high accuracy, indicating a promising direction for detection of individual patients with schizophrenia. Functional topological deficits of striatal areas may represent a focal neural deficit of negative symptomatology in schizophrenia.

Keywords: connectome; graph analysis; machine learning; magnetic resonance imaging; neuroimaging; psychosis.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
The overall pipeline of graph convolutional network model. (A) Graph construction for each individual using resting-state functional connectivity. (B) The architecture and implementation of graph convolutional network. Note: GAP, global average pooling; HC, healthy controls; ReLu, Rectified Linear Unit; SCZ, schizophrenia.
Fig. 2.
Fig. 2.
Top 10 salient regions contributing to GCN and SVM classification. The size of each region indicates the magnitude of contribution. Bar plots are used to illustrate statistically significant differences in topological characteristics between patients with schizophrenia and controls. Note: AMYG, amygdale; ANG, angular gyrus; CAU, caudate; GCN, graph convolutional network; MTG, middle temporal gyrus; ORBsup, orbitofrontal gyrus, superior part; ORBsupmed, orbitofrontal gyrus, superior medial part; PAL, pallidum; PUT, putamen; REC, rectus; SFGdor, superior frontal gyrus, dorsal part; SFGmed, superior frontal gyrus, medial part; SVM, support vector machine; TPOmid, temporal pole, middle part; TPOsup, temporal pole, superior part.
Fig. 3.
Fig. 3.
Correlation between nodal efficiency in the bilateral putamen and pallidum with severity of negative symptoms in individuals with schizophrenia.

Similar articles

Cited by

References

    1. Javitt DC. Balancing therapeutic safety and efficacy to improve clinical and economic outcomes in schizophrenia: a clinical overview. Am J Manag Care. 2014;20(8 suppl):S160–S165. - PubMed
    1. Regier DA, Narrow WE, Clarke DE, et al. . DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry. 2013;170(1):59–70. - PubMed
    1. Chmielewski M, Clark LA, Bagby RM, Watson D. Method matters: understanding diagnostic reliability in DSM-IV and DSM-5. J Abnorm Psychol. 2015;124(3):764–769. - PMC - PubMed
    1. Miller PR. Inpatient diagnostic assessments: 2. Interrater reliability and outcomes of structured vs. unstructured interviews. Psychiatry Res. 2001;105(3):265–271. - PubMed
    1. Boeke EA, Holmes AJ, Phelps EA. Toward robust anxiety biomarkers: a machine learning approach in a large-scale sample. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020;5(8):799–807. - PMC - PubMed

Publication types